[1]
Voortman, M. et al. 2018. Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis: Interpretability of the SFNSL. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 35, 4 (Nov. 2018), 333–341. DOI:https://doi.org/10.36141/svdld.v35i4.7260.